Helminth Therapy

Helminth Therapy refers to experimental approaches using controlled exposure to parasitic worms or worm-derived molecules to modulate immune responses, based on observations that helminth infections can reduce autoimmune and inflammatory disease severity through immune regulation. This concept leverages helminth-induced shifts towards regulatory immune pathways.

The pharmaceutical industry explores helminth-derived immunomodulators as potential sources of novel biologics and small molecules for autoimmune diseases. Rather than using live organisms, development efforts focus on identifying specific helminth proteins or metabolites that drive beneficial immune effects while avoiding infection-related risks. Translating helminth immunology into safe, scalable therapies requires rigorous characterisation, reproducible manufacturing, and controlled dosing approaches. Regulatory pathways would demand strong safety justification given the unconventional origin. As immune-mediated diseases remain major unmet needs, helminth-inspired strategies continue informing research into next-generation immunomodulatory therapeutics.